Tests a brain-healthy diet in people with multiple sclerosis
Tests whether a MIND-style diet improves thinking and memory in adults with multiple sclerosis.
Plain-language title generated from the registry record
Registry title: Remote Evaluation of MIND Diet
Key facts
- Where
- Urbana, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Source: NCT06450977, who can take part
Where in United States
- University of Illinois Urbana-ChampaignUrbana, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Illinois at Urbana-Champaign
- Trial code
- NCT06450977
- Record updated
- 27 June 2024
- Original description
The goal of this clinical trial is to learn if increasing adherence to a Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet pattern improves thinking ability and memory compared to a healthy control diet in persons with Multiple Sclerosis (MS). The main question it aims to answer is:Read full original descriptionShow less
Remote Evaluation of MIND Diet
The goal of this clinical trial is to learn if increasing adherence to a Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet pattern improves thinking ability and memory compared to a healthy control diet in persons with Multiple Sclerosis (MS). The main question it aims to answer is:
Does the MIND diet improve cognitive performance relative to a control diet in persons with MS?
Participants will:
Consume one meal that follows the MIND diet or a control meal every day for 3 months, complete online surveys and cognitive testing before and after, and keep a record of the food they eat during the study.
Inclusion: Individuals aged 18-64 years old; Self-reported diagnosis of Multiple sclerosis (MS); 20/20 or corrected vision; No other neurodegenerative disease diagnosis; Stable disease-modifying therapy (DMT) within 6 months; Not Pregnant or lactating; No food allergies or intolerances; Able to consume study meals; Not enrolled in another dietary, exercise, or medication study during the study; Access to a computer/laptop with internet.
Exclusion: Enrolled in another dietary, exercise, or medication study during the study; Other neurodegenerative disease diagnosis; Disease modifying therapy (DMT) less than 6 months; Food allergies or intolerances; Individuals younger than 18 or older than 64 years old; No self-reported diagnosis of Multiple sclerosis (MS); Not 20/20 or uncorrected vision; Pregnant or lactating; Not able to consume study meals; No access to a computer/laptop with internet.